Loading...
OTCM
SFES
Market cap12mUSD
Jul 11, Last price  
0.78USD
1D
0.00%
1Q
-6.42%
Name

Safeguard Scientifics Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
-4.62%
Rev. gr., 5y
%
Revenues
0k
Net income
-10m
L-31.09%
-22,262,000-88,572,000-15,629,00054,561,000-37,615,00027,004,000-14,263,000-9,828,000
CFO
-3m
L+1.53%
-18,661,000-20,805,000-26,035,000-19,970,000-8,143,000-8,151,999-3,258,000-3,308,000
Dividend
Dec 29, 20230.35 USD/sh

Profile

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
IPO date
Mar 17, 1980
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
5,683
4,775
Unusual Expense (Income)
NOPBT
(5,683)
(4,775)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(5,683)
(4,775)
Net income
(9,828)
-31.09%
(14,263)
-152.82%
Dividends
(5,819)
Dividend yield
Proceeds from repurchase of equity
(75)
(2,939)
BB yield
Debt
Debt current
489
429
Long-term debt
2,009
2,498
Deferred revenue
Other long-term liabilities
50
50
Net debt
(18,710)
(31,790)
Cash flow
Cash from operating activities
(3,308)
(3,258)
CAPEX
Cash from investing activities
5,721
(4,662)
Cash from financing activities
(6,252)
(3,488)
FCF
(5,364)
(349)
Balance
Cash
9,517
20,172
Long term investments
11,691
14,545
Excess cash
21,208
34,717
Stockholders' equity
(731,594)
(721,766)
Invested Capital
752,873
758,070
ROIC
ROCE
EV
Common stock shares outstanding
16,221
16,337
Price
Market cap
EV
EBITDA
(5,364)
(4,504)
EV/EBITDA
Interest
Interest/NOPBT